FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072122 [Registered on: 08/08/2024] Trial Registered Prospectively
Last Modified On: 08/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Episiotomy wound management]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison between ayurved Regimen and conventional Regimen in management of post normal delivery patients 
Scientific Title of Study   A study to compare the efficacy of ayurvedic intervention with the conventional intervention in management of episiotomy wound- a non-inferiority open labelled randomized clinical trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sanika Sanjay Aphale 
Designation  Pg 1st year 
Affiliation  All India Institute pf Ayurveda 
Address  405 room number , 4th floor, academic block, All India institute of ayurved, New Delhi, Gautam puri

South
DELHI
110076
India 
Phone  09850785766  
Fax    
Email  sanika.aphale1412@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Swati V Gaikwad  
Designation  Associate professor  
Affiliation  All India Institute of Ayurveda 
Address  4th floor, academic block , all India institute of ayurved, Gautam puri , New delhi

South
DELHI
110076
India 
Phone  9270825656  
Fax    
Email  swativgaikwad369@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sanika Sanjay Aphale 
Designation  Pg 1st year 
Affiliation  All India Institute pf Ayurveda 
Address  Room no. 405, 4th floor,academic block , all India institute of ayurved, Gautam puri, New delhi

South
DELHI
110076
India 
Phone  09850785766  
Fax    
Email  sanika.aphale1412@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda, 4th floor,academic block, Gautampuri, New Delhi 110044, India  
 
Primary Sponsor  
Name  All India Institute of Ayurveda 
Address  All India Institute of Ayurveda, Gautampuri, Sarita vihar, New Delhi-110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanika Aphale  All India Institute of Ayurveda  Room no. 405, 4th floor, academic block , All India institute of ayurved, New delhi
South
DELHI 
09850785766

sanika.aphale1412@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMITTEE, AIIA, NEW DELHI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O94||Sequelae of complication of pregnancy, childbirth, and the puerperium. Ayurveda Condition: SUTIKA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Tb Cefuroxime and clavulanic acid twice a day Tb Aceclofenac 100mg,Paracetamol 325mg, Serratiopeptidase 15mg three times a day Betadine ointment and solution for local application
2Intervention ArmProcedure-dhUpana, धूपन (Procedure Reference: , Procedure details: done for 5 days, twice daily for 5-7 mins)
3Intervention ArmDrugClassical(1) Medicine Name: triphala guggul, Reference: sharangdhar samhita, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: -water), Additional Information: -
4Intervention ArmProcedure-aBya~ggaH, अभ्यंग  (Procedure Reference: Sharangdhar samhita, Procedure details: Jatyadi tail will be applied over episiotomy wound twice daily)
(1) Medicine Name: Jatyadi tail, Reference: Sharangdhar samhita, Route: Topical, Dosage Form: Taila, Dose: 15(ml), Frequency: bd, Duration: 7 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  ICD 11 code for episiotomy is JB44.1- Disruption of perineal obstetric wound
The following synonyms will be excluded –
1 Obstetrical breakdown of perineum
2 Disruption of perineal laceration repair in puerperium
3 Wound dehiscence
 
 
ExclusionCriteria 
Details  1. Post operative LSCS patients
2. Patients having asthma, COPD, dust allergies
3. Patient having 3rd and 4th degree tear,
paraurethral tear
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Healing of episiotomy wound  14th day post Normal vaginal delivery 
 
Secondary Outcome  
Outcome  TimePoints 
1.Reduction in the colony count of bacterias
2.Decrease in pH of lochia
 
5 days post Normal vaginal delivery
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

SYNOPSIS FOR MS (Ayu.) DISSERTATION

A STUDY TO COMPARE THE EFFICACY OF AYURVEDIC INTERVENTION WITH THE CONVENTIONAL INTERVENTION IN MANAGEMENT OF EPISIOTOMY WOUND- A NON-INFERIORITY OPEN LABELLED RANDOMIZED CLINICAL TRIAL

 

 

 


                                           Name of Scholar

 

                      Dr. Sanika Sanjay Aphale

 

   GUIDE                                                           CO-GUIDE                                           CO-GUIDE    

                                                  

Dr. Swati V. Gaikwad                        Prof. Dr. Sujata D. Kadam              Dr. Ruchi Arora

 

Associate professor                            Professor and head,                             Counsultant               

Dept of  PTSR                                    Dept of PTSR                                     Dept of  PTSR

AIIA , New Delhi                               AIIA , New Delhi                             AIIA , New Delhi                                                                    

                                                                         

        

                                                                                              

                                                                                                            

                                                                                         

                                                                                    

                                  DEPARTMENT OF STREE ROGA AND PRASUTI TANTRA

                     ALL INDIA INSTITUTE OF AYURVED, NEW DELHI

                                    (An autonomous organisation under the Ministry of Ayush, Govt of India)

            

                                                  Gautampuri, Saritavihar, New Delhi -110076

Batch -2023-2026                                                                                              Enrollment no-  23AIIAMMAM000023

                                                     CERTIFICATE

This is to certify that DR. SANIKA SANJAY APHALE, first year PG. (Ayu.) Scholar in the department of prasuti tantra evam stree roga, All India Institute of Ayurveda,

New Delhi has proposed her dissertation entitled

“A STUDY TO COMPARE THE EFFICACY OF AYURVEDIC INTERVENTION WITH THE CONVENTIONAL INTERVENTION IN MANAGEMENT OF EPISIOTOMY WOUND- A NON-INFERIORITY OPEN LABELLED RANDOMIZED CLINICAL TRIAL’’who is a bonafide student of this  Institute of 2023-2026 Batch.

 

 

 

 

 

 

 

 

                                                                                               (PROF.) DR. TANUJA NESARI

                                                                                           Director

                                                                                                   All India Institute of Ayurveda

 

 

 

 Date:

Place: New Delhi

                      

 

                                         

 

 

TITLE:

A study to compare the efficacy of ayurvedic intervention with the conventional intervention in management of episiotomy wound- a non-inferiority open labelled randomized clinical trial

 

RESEARCH QUESTION :

Whether there is a difference in efficacy in the management of episiotomy wound by ayurvedic and conventional interventions?

 

NULL HYPOTHESIS :

Ayurvedic intervention is not equally effective than the conventional intervention in the management of episiotomy wound

ALTERNATE HYPOTHESIS :

Efficacy of Ayurvedic intervention is not-inferior to that of the conventional intervention in the management of episiotomy wound

 

 

 

 

Introduction:

The disease burden of puerperal sepsis and its association with maternal mortality is of a great concern. It accounts for 11% of maternal mortality globally[1]On the other hand, WHO states that the world is running out of antibiotics and  dedicates the theme for world health day as ‘‘Antimicrobial resistance:no action today ,no cure tomorrow’’ way back in 2011. Ayurveda has a great potential to not only prevent the incidences of puerperal sepsis post normal vaginal deliveries but also holistically aid the smooth transition of puerpera and can in turn contribute effectively in reducing this crisis of antimicrobial resistance.

                           

                    

 

 

           

Contemporary Review:            

                                              Puerperium is a period following the child birth during which the anatomical organs and the physiology of body returns back to pre-pregnant state. The period of puerperium begins after the expulsion of placenta till 6 weeks when the uterus regresses to non-pregnant size.

                                         It is a state of low immunity due to wounds, lacerations in cervix,vagina,placental site and blood loss. The presence of a variety of microorganisms in vagina eg staphylococcus, e coli, clostridium,yeasts etc are likely to become virulent in this situation owning to lowered immunity. In India, it is a common practice to give antibiotics after episiotomy as prophylaxis ,maybe due to hygiene concerns.

                                        Episiotomy is a surgically planned incision taken on the perinium to facilitate the birth of the child during a vaginal delivery. There has been a controversy regarding usage of systemic antibiotics as prophylaxis for normal vaginal delivery episiotomy ( 2nd degree perineal tear)[2,4]. While some textbooks recommend the use of systemic antibiotics as prohylaxis in normal vaginal delivery episiotomy ( 2nd degree perineal tear) others don’t.  As per WHO guidelines oral antibiotics are not recommended in episiotomy .As per ACOG practice bulletin, antibiotics are only indicated in 3rd and 4th degree perineal tear.The DC Dutta textbook of obstetrics recommend the use of local antibiotic ointment along with oral analgesics but do not mention the use of systemic antibiotics[3]

 

                                            Administration of antibiotics may have adverse effect on both mother and the child. As a well-known fact the use of antibiotics causes a disturbance in the gut microbial flora which can lead to IBS , hormonal imbalances , metabolic diseases[7]. It also induces resistance to the antibiotics. The use of antibiotics in the mother decreases breast milk secretion and it also kills the good bacterias in vagina which leads to vaginosis of the puerperium.[5]

                                           Some antibiotics which are relatively safe during lactation are penicillins,clavulanic acids,cephalosporins,metronidazole at low doses . Analgesics like paracetamol , low dose aspirin are also considered compatable with breast feeding. [9]                   

 

 

Classical review

 

                        Episiotomy according to ayurved is Sudha chinna vrana which will follow the principals of vrana chikitsa for its management.[6]

                          Sutika, as described in the classics is a female who has delivered a baby. Sutika kaal is considered to be of 6 weeks Sushrut[7], ashtang hriday[8]  alternatively till the women starts menstruating, while kashyap mentions a period of 6 months[9] , as this period is required by the female to gain back the physiological state of the body.

                        Sutika Avastha is a very fragile condition because her body is emaciated due to development of the fetus and also empty due to blood loss during delivery , vitiation of vaat due to labour pains. Any disease in this condition would lead to the diseases that are very difficulty to cure, so all the samhitas have mentioned paricharya to avoid this from happening.

                       Thus the management of episiotomy wound in sutika avastha will require certain modifications in the treatment protocols mentioned in classics considering this physiological state. The classics expect vaidyas to use yukti Pramana to address this.

 

 Review of previous works:

                         

Sr no

Study title

Author

Drugs / methods used

Knowledge gap

1.

Validation of the effect of an ayurvedic therapeutic procedure, Dashmoolkwath and dhoopan – fumigation with medicinal herbs during first week of puerperium- an open clinical trial[10]

Dr Seema R. Gholap

DR N. V. khairnar

Dashmool kwath,

 yoni dhoopana with kushta, aguru,guggulu

1)Specificity of antimicrobial action of dhoopana dravyas used not mentioned

2) Details about dhoopana upakrama regading the length of dhoopana tube , distance from the opening of tube from the wound,temperature of dhoopana  not mentioned

3) REEDA SCALE for episiotomy wound healing not used

 

2

Determining the efficacy of combination of three ayurvedic formulations and dhoopana in prevention of infections post vaginal delivery with episiotomy[11]

Dr Swati Mohite

Vidanga, shatapushpa,jatamansi, guggulu sprinkled on embers  and dhoopana done with the fumes.

Balant kadha

Saubhagya shunthi paak

Shatavari kalpa

1)REEDA SCALE for episiotomy wound healing not used

2)Specificity of antimicrobial action of dhoopana dravyas used not mentioned

3)standardization regarding temperature of dhoopana not done

 

3

Clinical efficacy of local guggulu dhoopana in management of episiotomy wound[12]

Dr Garthe limbanappa Somnath

Dr Ravikiran Ram Bhosale

Ghrita and guggulu dhoopana

1)laboratory investigations not done to support the clinical findings

4

Evaluation of Dhoopana karma in sutika paricharya[13]

Dr Vidyaa Maruti Magar

Dr S R Gholap

Kushta ,aguru,guggulu

dhoopana

Specificity of antimicrobial action of dhoopana dravyas used not mentioned

 

 

 

 

 

 

 

Need of research :

 

1.     The research work done previously show that episiotomy can be managed by ayurvedic regimen but the spectrum of antimicrobial action is not mentioned clearly.

2.     If ayurvedic regimen has to be implemented in episiotomy wound management, more RCTs taking antibiotics as the comparator group is needed in order to have a thorough comparative analysis

 

 

 

 

Primary objectives:

.To study the efficacy of ayurvedic intervention in episiotomy wound management and compare its effectiveness with the conventional intervention.

Secondary objectives:

1.    To assess the effect of yoni dhoopana on lochia

2.    To assess in-vivo antimicrobial action of the formulations used

3.    To examine the possible mode of action of the upakrama and dravyas used

4.    To examine adverse effects if any

Outcome measures:

PRIMARY OUTCOME:

 

1)     Healing of episiotomy wound

 

SECONDARY OUTCOME:

 

1) Reduction in the colony count of bacterias

2) Decrease in pH of lochia

 

Materials and methods

Plan of Study-

1)    Literature review-

-        Drug Review

-        Episiotomy Wound healing Review

2)     Pharmaceutical review-

-        Procurement of RAW material

-        Identification and authentication of Raw drugs

3)    Clinical study

 

Drug review:

Triphala guggulu – will be procured from GMP certified pharmacy

अथ त्रिफला गुग्गुलुर्भगन्दरादौ –

त्रिपक्षं त्रिफलाचूर्णं  à¤•ृष्णाचूर्णं पलोन्मितम् ।

गुग्गुलुं पाञ्चपलिकं क्षोदयेत्सर्वमेकतः ॥ ८२ ॥

ततस्तु गुटिकां कृत्वा प्रयुञ्ज्याद्वन्ह्यपेक्षया ।

भगन्दरं गुल्मशोथावर्शांसि च विनाशयेत् ॥ ८३ ॥

                                                                ( शा.सां.म.खां.82-83 )

 

 

 

 

 

Sr no

Name of ingredient

Latin name

family

Part used

1

Haritaki

Terminalia chebula Retz.

Combretaceae

Fruit

2

Amalaki

Phyllanthus emblica L.

Euphorbiaceae

Fruit

3

Bibhitaki

Terminalia bellirica Retz.

Combretaceae

Fruit

4

Pippali

Piper longum linn.

piparaceae

Fruit

5

Guggulu

Commiphora wightii Linn.

Burseraceae

Resin

 

 

 

 

 

 

 

 

 

     Dhoopan Dravya :

Sr no

Name of ingredient

Latin name

Family

Parts used

1

Sarjarasa

Vateria indica Linn

Dipterocarpaceae

Resin

 

Procurement :The drug will be procured from the market

Authentication: The drug will be authenticated from Pharmacognosy lab, AIIA, New Delhi

 

 

 

 

 

Jatyadi Tail: will be procured from GMP certified pharmacy

जातीननम्बपटोलानाां नक्तमालस्य पल्लवााः ।। 168 ।।

नसक्थांसमधुकां कुष्ठां द्रेननशेकटुरोनहणी ।

पद्मकां लोध्रमभया नीलमुत्पलम्।। 169।।

 à¤¤à¥à¤¤à¥à¤¥à¤•ां साररवा बीजांनक्तमालस्य दापयेत्।

 à¤à¤¤à¤¾à¤¨à¤¨ समभागानन नपष्ट्वा तलैनवपाचयेत्।। 170।।

नाडीव्रणेसमुत्पन्नेस्फोटकेकच्छुरोनगषु।

 à¤¸à¤¦à¥à¤¯à¤¾à¤ƒ शस्त्रप्रहारेषुदग्धनवद्धेषुचव नह ।।  171 ।।

 à¤¨à¤–दन्तक्षतेदेहेव्रणेदुष्टेप्रशस्यते। (शा.सां.म.खां. 9/168-17)

 

 

 

 

Contents of Jatyadi Tail

 

 

 

 

STUDY DESIGN- Open labelled randomized clinical trial

STUDY TYPE- Interventional

TIMING- Prospective

DURATION-7 days

DRUG FREE FOLLOW UP-14th,45th day after vaginal delivery

END POINT- Healing of episiotomy wound

SAMPLE SIZE- 60 ( 30 in each group )

RANDOMIZATION:  Variable Block Randomization

 

 

Plan of study: 

Time- Within 24hrs of Normal vaginal delivery

Treatment plan :  A) Internal Medication

                            B) local treatment

A)   Internal Medication- Tablet triphala guggulu 500mg twice a day before food

 

B)    Local treatment – The following treatment will be done twice a day for 5 days

 

STANDARD OPERATIVE PROCEDURE  FOR DHOOPANA-

 

{ To be done twice daily at the interval of 10-12 hrs}

 

Patient is asked to evacuate the bladder and bowel before therapy

            

Cleaning the episiotomy wound with Sterile water in lithotomy position and drying it

New disposable sheets will be used for every patient on each day of dhoopana

 


                      

   5gm of sarjarasa powder will be sprinkled on 75gm of red hot charcoal with 5ml of

   ghee  in a mud pot  (shaarav)  until sufficient quantity of fumes are created

 

 

 


       Patient is made to sit on a wooden chair having diameter of approximately 30cm

        such that  the episiotomy wound on the perineum is exposed to the fumes.

The distance of perineum will be approximately about

50cm ( janu tulya aasan ) from the upper border of shaarav

                          

 

      Dhoopana will be done for 5-7 mins

 

 

 

 

 

 

 

 

 STANDARD OPERATIVE PROCEDURE FOR APPLICATION OF JATYADI TAIL:

 { To be done twice daily at the interval of 10-12 hrs}

 

 

After the dhoopana, patient will be given lithotomy position

 

 


Autoclaved jatyadi oil will be taken on a gauze in sufficient quantity according to the size of wound ( approximately 15-20 ml)

 

 


The gauze will be placed over the episiotomy wound and will be removed after 5 mins.

          

            

 

 

GroupA

(Control group)

Tb Cefuroxime and clavulanic acid twice a day

Tb Aceclofenac 100mg+ Paracetamol 325mg+ Serratiopeptidase 15mg three times a day

Betadine ointment and solution for local application

Group B

(Trial group)

Yoni Dhoopan with sarjarasa, local application of jatyadi tail done twice daily and tb triphala guggulu 500mg twice a day before food

 

 

 

 

 

 

 

 

Drug Delivery Regimen:

 

GROUP

DRUG

ROUTE AND DOSE OF ADMINISTRATION

DURATION

A

Tb Cefuroxime and clavulanic acid

Oral – twice a day- after food with water

5

 

Tb Tb Aceclofenac 100mg+ Paracetamol 325mg+ Serratiopeptidase 15mg

Oral – twice a day- after food with water

7

 

Betadine solution and ointment

Local – As per size of episiotomy

7

 

Tb Triphala guggulu 500mg

Oral – twice a day- after food with water

7

B

Sarjarasa dhoopana

Local – As per size of episiotomy

5

 

Jatyadi tail

Local – As per size of episiotomy

7

 

Duration of trail – 7 days

 

Follow up period –14th , 45th days

 

sample size  --

                          As per the practices at AIIA, we have seen at least 90% success rate in achieving complete wound healing, where as pervious clinical trials suggest 85% success rate in achieving complete wound healing using ayurvedic intervention. However, we wish to explore if ayurvedic intervention can replace the conventional intervention. Therefore, a non-inferiority clinical trial is being conducted. It is assumed that the proposed ayurvedic intervention may help to achieve complete healing in 85% of cases, assuming 10% non-inferiority margin, 80% power , 5% level of significance

The calculated sample size in each group is 60 (67 with 10% drop out)

Due to time constraint, the sample size will be taken as 60 (30 in each group) 

 

 

 

 

Enrollment Of Patients:

All the patients will be enrolled from Labour room and ANC OPD of All India Institute of Ayurved, New Delhi.

 

 

 

 

Inclusion criteria:

1.     Patients of age group 20-40 years of age

2.     Patients with normal vaginal delivery with episiotomy( 2nd degree perineal tear)

ICD 11:

ICD 11 code for episiotomy is JB44.1- Disruption of perineal obstetric wound

The following synonyms will be excluded –

-        Obstetrical breakdown of perineum

-        Disruption of perineal laceration repair in puerperium

-        Wound dehiscence

 

Exclusion criteria:

  1. Post operative LSCS patients
  2. Patients having asthma, COPD, dust allergies
  3. Patient having 3rd and 4th  degree tear,

             paraurethral tear

      4.  Patient with DM, severe anemia[hb<8gm/dl],   other immunocompromised conditions.

      5.  Patients with vaginosis , vaginitis, cervicitis or PID

      6.   Breast abscess, mastitis

      7.   Patients not willing to participate

 

 

Investigations before treatment:

CBC with ESR,

 APTT,PTINR,

LFT,KFT,

RBS F, RBS-PP,

URINE Routine -Microscopy,

HIV ANTIBODY 1 and 2,

Anti HCV,

HBsAG,  VDRL.

 

 

 

 

 

 

 

 

 

 

Parameters for assessment :

 

 

 

A.    PAIN SCALE-  ( assessed on 0,1,2,3,4,5 days post-NVD) [14]

 

 

 

 

B.    CBC WITH ESR(0th ,5th day)

 

        C.Swab culture(0th ,5th day)

 

        D.ph of lochia(0th to 5th day post NVD)

 

        E.REEDA CRITERIA-(0th, 3rd,5th)[15]

 

            F. Quantity of Lochia-( 7 consecutive days post NVD )[16]

 

 

 

 

 

 

 

Points

Redness

Edema

Ecchymosis

Discharge

approximation

0

None

None

None

None

Closed

1

<0.25cm of incision bilaterally

<1cm from incision

<0.25cm bilaterally or 0.5cm unilaterally of incision

serous

Skin separation <3mm

2

<0.5cm of incision bilaterally

1-2cm from incision

<0.25cm-1cm bilaterally or 0.5cm-2cm unilaterally of incision

serosanguinous

Skin and subcutaneous fat separation

3

>0.25cm of incision bilaterally

>2 from incision or affects vulvar area

>1cm bilaterally or 2cm unilaterally of incision

Bloody purulent

Skin and subcutaneous fat separation

Healed :0             Moderately healed:1-5                  Mildly Healed :6-10        Not healed:11-15   

 

 

 

 

 

 

 

         DAYS

  

 

 

PARAMETERS

0th day

3rd day

5th day

REEDA

 

 

 

 

WBC COUNT

 

 

-------------

 

ESR COUNT

 

 

--------------

 

Table : assessment parameters

 

 

 

        PARAMETERS

 

 

 

 

 

DAYS

 

           PAIN

            pH   of LOCHIA             

 

PADS STAINED PER DAY

(280mm) with nature of discharge

 

Before dhoopana

After dhoopana

Before dhoopana

After

dhoopana

Involution of uterus below umbilicus

0

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table : assessment parameters

 

 

 

Assessment of result:

· The data would be presented in the form of Descriptive Statistics such as Mean ± SD, SEM or Range etc., whichever is applicable. The data would be depicted in the form of Tables, Charts, Graphs, Diagrams etc., wherever it is applicable.  Data related to all the intend to treat participants would be considered for safety related assessments and those completing the course of treatment (Per protocol) would be considered for efficacy assessment

· The data generated is subjected to normality test with Shapiro- Wilk test. If normality test is passed, parametric test would be employed otherwise non parametric test is employed. 

· For objective data, paired‘t’ test will be employed to assess before and after treatment differences within the groups and unpaired ‘t’ test will be employed for assessing the differences within the groups.

· For subjective data, Wilcoxon signed rank test will be employed to assess before and after treatment differences within the groups.

· Mann- Whitney U test will be employed for assessing the difference between the trial and control groups.

· For multiple comparisons of more than 2 sets within the same group – repeated period of ANOVA for parametric data and Friedman’s test for non-parametric data would be used.

· P valve ≤ 0.05 will be considered as statistically significant.

· IBM SPSS Statistics application for Windows, version 26 will be used for analysis.

· Clinical effect size would also be determined using design appropriate methods

 

 

 

Investigations:

1)CBC WITH ESR (0th  ,5th   day )

 2) swab culture (0th,5thday)

             3) Ph of lochia (5 consecutively days post NVD)

 

 

 

Withdrawal criteria:

1.     Signs of sepsis (temp>100.4 F, pulse rate>90bpm, subinvoluted and tender uterus , wbc count more  than 12000cumm)

2.     Purulent or Blood stained lochia

3.     Breast abscess, mastitis

 

ADR Reporting:

Adverse drug reaction will be reported to Pharmacovigilance centre of AIIA,New Delhi

 

Translational Value:

  1. Reducing the burden of antibiotic resistance
  2. Protecting the child and the mother from adverse effects of systemic antibiotics
  3. Holistic management of sutika by ayurvedic regimen
  4. Cost effectiveness

 

Rescue medication: Patient will be withdrawn from trial group and will be given antibiotics and painkillers or resuturing if needed

Patient Compliance :   A patient information sheet will be provided to patient in printed format. Information regarding the purpose, treatment plan, benefits and possible risks will be explained to the patient individually. Patients will be admitted in the ward for 5 days. 

Drug Compliance :  A drug compliance chart will be given to the enrolled patients.

Data Confidentiality : Data collected during the study will be stored securely and will be used for analysis.

The Researcher, guide and co-guides, IEC, AIIA, New Delhi and other regulatory bodies will have access to the records.

Provision for Continued Patient Care: The patient will be handed over to the primary consultant for other routine medications (if required)

Monitoring of Study:  Study will be monitored by the IRB committee, scholar, guide and co-guides

 

References:

 

1.     Kaur H, Kaur S, Mattu S, Nandrajog A. Burden of puerperal sepsis and its relation with maternal mortality. International Journal of Reproduction,Contraception,Obstetrics,Gynecology 2023;12:3103-8

2.    Thitipong S. Incidence of postpartum infections and outcomes associated with antibiotic prophylaxis after normal vaginal delivery 2019,58;233-43

3. Dutta D.C, Textbook of obstetrics, Operative obstetrics,episiotomy,10th      edition,New Delhi:Jaypee brothers medical publishers,2023;p.259

4.     Mohammed NA,Hanafy NM,effect of post episiotomy antibiotics on maternal infectious morbidity, JRAM,2022;3(1);31-37

5.     Chenyang Ji,Geer Zhang,Siyuan Xu,Qingyi Xiang,Meishuang Huang,Meirong Zhao et al.Antibiotic treatments to mothers during the perinatal period leaving hidden trouble on infants, European Journal of Pediatrics,2022;181(9):1-13

6.    Shastri A D,editor,(1st ed.), Sushrut Samhita ,poorvardha, chikitsasthan, Chapter 2, verse 10. Varanasi: Choukhamba Sanskrit Sansthana ,2019; p.19

7.    Shastri A D,editor,(1st ed.), Sushrut Samhita ,poorvardha, sharirsthan, Chapter 10, verse 18.Varanasi:Choukhamba Sanskrit Sansthana,2019; p.103

8.    Shastri HS,editor,(1st ed.),Commentary by Arundutta and Hemadri on Ashtanga Hridayam of Vagbhata, Sharirsthan,Chapter10,verse 100/101, Varanasi:Choukhamba Sanskrit Sansthana,2022;p.102.

9.    Shaarma H,Vridhajivaka,Kashyap samhita,revised by vatsya with Sanskrit introduction with vidyotini hindi commentary,khilsthana,chapter 11,sutikupakramaniya,12,Varanasi:Choukhamba Sanskrit Sansthana,2000;  p.211.

10.      Gholap SR, Nar NV. Validation of the effect of an Ayurvedic procedure, Dashmoolkwath, and Dhoopan – fumigation with medicinal herbs during the first week of puerperium: An open clinical trial. Int J Ayurveda Med Sci. 2017;2(2):146-152.

11.       Mohite S.Determining efficacy of Combination of three ayurvedic formulations and dhoopana (medical fumigation  in prevention of infections post vaginal delivery with episiotomy), International Journal of Science and Research January 2013 ;4(1):2319-7064

 

12.      Garthe, L. S., & Bhosale, R. R. Clinical Efficacy of Local Guggulu Dhoopana in Management of Episiotomy Wound. Ayurlog: National Journal of Research in Ayurved Science,2021; 9(03).

13.  Magar V and Gholap S , Evaluation of dhupan  karma in sutika paricharya. World journal of pharmacy and pharmaceautical sciences , 2017; 6(03): 607-621

14.      Bird SB, Dickson EW. Clinically significant changes in pain along the visual analogue scale,200;,38:639-643

15.      Rev Lat Am Enfermagem, Episiotomy healing assessment : REEDA scale reliability 2015;23(1);162-168

16.      Hitmer T. Physical and psychologic changes. In: Mattson S, Smith JE, editors. Core curriculum for maternal-newborn nursing. 4th ed. St. Louis, MO: Saunders Elsevier 2011; p. 301-314.

 

 

 

 

 

 

 

 
Close